Objective: to establish a possible role for autoimmunity in the aetiology of abdominal aortic aneurysm (AAA) by examining human leukocyte antigen class II (HLA-II) immune response genes. Materials and Methods: HLA-II typing was performed in a series of 72 AAA patients and a control group of 380 healthy subjects. Results: a higher incidence of the allele subtype HLA-DR B1 B 0401 was detected in the AAA group with respect to the control group (12.5 vs 5.2%; p 0.02, OR 2.59). In contrast, the HLA-DR B1 B 01 allele tended to behave as a protective factor for AAA (12.5% AAA vs 21.3% controls; p 0.09, OR 0.5). Conclusions: the association observed here between HLA-DR B1 B 0401 and HLA-DR B1 B 01 and unspecific AAA is similar to that reported in several autoimmune diseases. This similarity suggests an essential role for autoimmune factors in the formation of the AAA.
Introduction
The aetiology of abdominal aortic aneurysm (AAA) remains unclear. The possible role played by autoimmunity, and its relationship with matrix metalloproteinases, remains inconclusive. 1±5 In autoimmune diseases, the major human histocompatibility complex is known to be involved in the presentation of autoantigens to host immune cells. Tilson et al. 6 and Hiroshe et al. 7 reported an association between the human leukocyte antigen class II (HLA-II) immune response gene HLA-DR2 and AAA in two studies performed on small series of Black and Japanese populations, respectively. Rassmussen et al. 8 were also able to associate HLA-DR2 and HLA-DR4 with AAA. This study was designed to evaluate possible associations between alleles of the HLA-II immune response gene and AAA in a European population group.
Materials and Methods
The 11 main alleles of the HLA-DR B1 locus were typed in a group of 72 consecutive patients who had undergone infra-renal AAA repair. Patients with an inflammatory aneurysm and those showing signs or family history of an autoimmune disease were excluded from the study. All the patients were white and born in Spain with Spanish ancestors. The usual risk factors were present ( Table 1 ). The control group comprised 380 white subjects with no known autoimmune disease or cardiovascular pathology. They were all Spanish, live in the number seven health area in Madrid, and a representative sample of our community. These subjects were recruited from our centre to establish a DNA bank for use as the control group in several autoimmune pathology studies.
DNA was extracted from leukocytes previously isolated from 10 ml blood samples preserved in EDTA as the anticoagulant at 4 C until processing. Once the DNA was extracted, amplification of the relevant gene sequence was performed by polymerase chain reaction (PCR) to provide a sufficient number of copies to work with. The reaction mixture was processed in a thermocycler under the following conditions: initial hybridisation at 95 C for 4 min, 35 cycles of 20 s at 95 C, 20 s at 55 C and 30 s at 72 C, and a final extension stage of 7 min at 72 C. EcoTaq DNA polymerase was the enzyme used for amplification. The different HLA-DR B1 alleles were identified using specific oligonucleotide probes (Dot-Blot) according to the method described by Verduyn et al. 9 The probes are DNA fragments whose base sequence is complementary to the sequence to be identified. These probes are labelled with digoxygenin-ddUTP, such that the different alleles can be detected by developing photographic plates exposed to the marker.
The DNA typing data were introduced into a Microsoft Access database. Statistical analysis was performed using the Epi-info programme by the 1 2 -test (using Yates' or Fischer's correction when needed) to compare the patient and control groups. The level of statistical significance was set at p 5 0.05. The associated risk of AAA was evaluated in terms of the odds ratio (OR) and 95% confidence interval (95% CI).
Results
No significant differences were detected in the frequencies of the different HLA-DR alleles between the patient and control groups ( Table 2 ). However, the HLA-DR B1 Ã 01 allele showed a tendency to behave as a protective factor against AAA. This allele showed an incidence of 12.5%, compared to 21.3% recorded in the healthy control group (p 0.09; OR 0.5, 95% CI 0.23±1.15). In contrast, the HLA-DR B1 Ã 04 allele showed a predisposing tendency for the disease with a 30.5% incidence in the AAA group, compared to 21.1% in the healthy controls (p 0.08; OR 1.7, 95% CI 0.90±2.98). To establish whether these tendencies were attributable to certain subtypes of these alleles, we also determined subtype frequencies. No significant difference was detected in the incidence of the HLA-DR B1 Ã 01 subtypes between the two groups (Table 3 ). However, the Ã 0401 subtype of the HLA-DR B1 Ã 04 allele did appear as a risk factor for AAA, showing an incidence of 12.5% compared to the 5.2% shown by the control group (p 0.02; OR 2.6, 95% CI 1.03±6.3) ( Table 4 ).
Discussion
The role of inflammatory cells in the aetiology of AAA is currently being explored by several investigators, who have attempted to establish a relationship between the disease and the expression of certain metalloproteinases that might alter the normal structure of collagen and elastin in the aortic wall. 1±5 In a histological study, in which several lymphocyte populations were quantified using monoclonal antibodies, Koch et al. 10 demonstrated altered amounts of these populations in aortic arteriosclerosis. These authors suggested the occurrence of an inflammatory process in the aortic wall as a response to autoimmune insult. Increased levels of metalloproteinases such as streptomelisin (MMP 3), collagenase (MMP 1) and gelatinase B (MMP 9) in the aortic wall are thought to modify the normal structure of collagen and elastin in the adventitial layer of the aorta leading to its dilation. The rise in levels of these proteolytic enzymes is induced by cytokines such as the tumour necrosis factor and interleukin-1, which are found in increased amounts in the aortic wall. 4,11±14 Tilson et al. 6 demonstrated how an Ig-G immunoglobulin purified from the wall of the AAA was immunoreactive with an 80 Kd protein of the normal aortic wall, and that this protein was located in the adventitia. This Ig±G isolated from the AAA wall, therefore, acts as an autoantibody against a protein normally found in the aortic adventitia. 15 This reaction could thus trigger the inflammatory process giving rise to the increase in cytokines and, in turn, to the rise in metalloproteinases, inducing the degradation of the aortic wall.
There are, therefore, many features that suggest that AAA could be of an autoimmune nature. In this type of disease, the human major histocompatibility complex, particularly the HLA-DR antigen, plays a key role. Thus, the prototype autoimmune disease, rheumatoid arthritis, has been associated with the presence of the HLA-DR B1 Ã 0401 allele. 16 Some authors have also demonstrated a relationship between HLA-DR B1 Ã 02 and AAA. Tilson et al. 6 were able to observe such a relationship in a small group of Black North Americans. Rasmussen et al. 17 reported similar results in a North American population with inflammatory AAA. In a similar study performed on 46 Japanese patients with AAA and 50 healthy controls, Hirose et al. 7 confirmed Rasmussen's results for the mixed North American population. Moreover, Rasmussen et al. 8 recently published a further study in which they were able to note an association between HLA-DR B1 Ã 02 and HLA-DR B1 Ã 04 and AAA. These authors also observed that HLA-DR B1 Ã 01 behaved as a protecting factor for this disease. These findings are in part similar to those observed here, in that we found the same associations between AAA and the DR B1 Ã 04 and DR B1 Ã 01 alleles. Further, we were able to identify the DR B1 Ã 04 subtype responsible for the genetic susceptibility which appeared as a risk factor for the development of AAA (p 0.03; OR 2.6, 95% CI 1.03±6.3). It should be highlighted that this is the first study to identify the allele subtype responsible for this association. Though similar interactions have been reported in other diseases of an autoimmune character. As mentioned above, the HLA-DR B1 Ã 0401 subtype has been associated with the typically autoimmune disease rheumatoid arthritis. 16 These two diseases do not have any apparent relationship. This could be explained by linkage disequilibrium. HLA-DR B1 Ã 0401 is associated with severe forms of rheumatoid arthritis. This does not mean that this gene is responsible for the development of the disease, but it marks a susceptibility to suffer it because it is inherited with a gene which encodes an inflamation factor and which is placed very close by in tha DNA chain. This is applicable to our case and to most of currently classified as autoimmune diseases. The difference could lie in the autoantigen which starts the disease. Besides, there is a similarity between two diseases: In rheumatoid arthritis the sinovia is actively infiltrated by limphocytes, mainly CD4 cells, surrounding the tissue vessels. This same phenomenon occurs in AAA, as Koch et al. 10 described. Reduced HLA-DR B1 Ã 01 expression has also been described in giant cell arthritis, an autoimmune disease involving the inflammation of the arterial wall. 18 In our study performed on a Spanish population, no relationship between HLA-DR B1 Ã 02 and AAA, such as that observed in American and Japanese patients, was detected. The fact that AAA has been linked to different alleles depending on the study population could reflect genetic variation among races, such as occurs in other autoimmune diseases.
In conclusion, the results of this and other studies suggest that autoimmune phenomena can play an important role at some stage in the aetiology of the AAA. These findings could have implications in new diagnostic applications. The over two-fold increase in the risk of AAA associated with HLA-DR B1 Ã 0401 is sufficient to consider it a genetic marker, which could be used for screening populations at risk of cardiovascular disease. From a therapeutic stand-point, this association suggests the possibility of applying immunomodulatory agents to inhibit the inflammatory process and thus stall aneurysm enlargement. Notwithstanding, it is clear that much further work in this field is needed if we are to fully understand the role of inflammation and autoimmunity in the genesis of what is presently refered to as an unspecific aneurysm of the abdominal aorta.
